Luca E. Vago
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 99 publications
Donor Selection and Human Leukocyte Antigen Loss Leukemia Relapse After Hematopoietic Cell Transplantation.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 25, 2026
The conditional benefit of being alive and disease free at 2 years after transplant: a long term survival evaluation among 456 patients affected by acute myeloid leukemia.
Journal: Frontiers in immunology
Published: February 26, 2026
Long-term remission of neuromyelitis optica with allogeneic hematopoietic stem cell transplant.
Journal: Med (New York, N.Y.)
Published: October 30, 2025
Safety and effectiveness of the combination of 5-azacitidine and ruxolitinib in VEXAS syndrome: A single-centre experience.
Journal: British journal of haematology
Published: September 18, 2025
Therapy induced senescence promotes immunogenicity in acute myeloid Leukemia through reduced EZH2 activity.
Journal: Nature communications
Published: August 27, 2025
CC486 as a safe and effective bridge to transplant in MDS-del5q with transfusion-dependent anemia following lenalidomide relapse: A case report.
Journal: Current research in translational medicine
Published: May 26, 2025
Impact of letermovir on cytomegalovirus-specific T-cell reconstitution after allogeneic hematopoietic stem cell transplantation in the post-transplant cyclophosphamide era.
Journal: Haematologica
Published: May 26, 2025
Validation of Manhattan risk to predict aGvHD severity in Rapamycin and PTCy-based prophylaxis: a study on 459 consecutive HCT patients.
Journal: Bone marrow transplantation
Published: March 03, 2025
Last Updated: 09/26/2026